Mattia Galli/LinkedIn
Dec 19, 2025, 12:07
OCEAN Trial: Rethinking Long-term Anticoagulation after Atrial Fibrillation Ablation
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal, posted on LinkedIn:
”Can we drop oral anticoagulant therapy after successful atrial fibrillation ablation?”
Read the full article here.
Title: OCEAN trial: rethinking long-term anticoagulation after atrial fibrillation ablation
Authors: Mattia Galli, Beatrice Simeone, Sebastiano Sciarretta

Stay updated with Hemostasis Today.
Anticoagulation
Atrial Fibrillation
Atrial Fibrillation Ablation
Beatrice Simeone
Cardiology
ESC
European Heart Journal
European Society of Cardiology
Health
Heart Health
Hematology
Hemostasis
Hemostasis Today
Long-term Anticoagulation
Mattia Galli
Medicine
OCEAN Trial
Sapienza University of Rome
Sebastiano Sciarretta
thrombosis
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice